DRUG-LADEN LIPOSOMES IN ANTITUMOR THERAPY AND IN THE TREATMENT OF PARASITIC DISEASES

被引:9
作者
CROMMELIN, DJA
NASSANDER, UK
PEETERS, PAM
STEERENBERG, PA
DEJONG, WH
ELING, WMC
STORM, G
机构
[1] Dept of Pharmaceutics, University of Utrecht, 3522 AD Utrecht
[2] Lab. for Pathology, National Institute for Public Health and Environmental Protection, 3720 BA Bilthoven
[3] Dept. Cell Biology and Histology, University of Nijmegen
关键词
antitumor drug delivery; cancer chemotherapy; drug targeting; immunoliposomes; liposomes; malaria chemotherapy;
D O I
10.1016/0168-3659(90)90136-H
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
To fully understand the potential and limitations of drug-laden liposomes in therapy, it is necessary to have information available on the behaviour of both drug and liposome in the body after administration. For two cytostatics (doxorubicin and cisplatin) the effect of liposome encapsulation on the therapeutic index was studied in tumor-bearing rats. Data were collected on the fate of liposome and drug in the rats. Analysis of these data provided a possible explanation for the observation that liposome encapsulation increased the therapeutic index for doxorubicin, but not for cisplatin. In the second part of this article the beneficial effect of liposome encapsulation of chloroquine (CQ) on the treatment and prophylaxis of murine malaria is demonstrated. This effect could be ascribed to sustained release of CQ from the intraperitoneally injected liposomes. Finally, examples of successful drug targeting with CQ containing immunoliposomes, or successive administration of antibodies and CQ containing liposomes, in a murine malaria model are presented. © 1990.
引用
收藏
页码:233 / 243
页数:11
相关论文
共 23 条
[1]  
Gregoriadis, Liposome Technology, Vols. 1, 2 and 3, (1984)
[2]  
Gregoriadis, Liposomes as Drug Carriers: Recent Trends and Progress, (1988)
[3]  
Ostro, Liposomes: from Biophysics to Therapeutics, (1987)
[4]  
Roerdink, Daemen, Bakker-Woudenberg, Storm, Crommelin, Scherphof, Therapeutic utility of liposomes, Drug Delivery Systems: Fundamentals and Techniques, Ellis Horwood Series in Biomedicine, pp. 66-80, (1987)
[5]  
Machy, Leserman, Research in Liposomes in Cell Biology and Pharmacology, (1987)
[6]  
Storm, Van Bloois, Brouwer, Crommelin, The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation, Biochim. Biophys. Acta, 818, pp. 343-351, (1985)
[7]  
Storm, Roerdink, Steerenberg, De Jong, Crommelin, Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model, Cancer Res., 47, pp. 3366-3372, (1987)
[8]  
Steerenberg, Storm, De Groot, Claessen, Bergers, Franken, Van Hoesel, Wubs, De Jong, Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution, Cancer Chemother. Pharmacol., 21, pp. 299-307, (1988)
[9]  
Van Hoesel, Steerenberg, Vos, Hillen, Dormans, Antitumor effect, cardiotoxicity and nephrotoxicity of doxorubicin in the IgM solid immunocytoma-bearing Lou/M Wsl rat, J. Natl. Cancer Inst., 72, pp. 1141-1150, (1984)
[10]  
De Jong, Steerenberg, Vos, Bulten, Verbeek, Kruizinga, Ruitenberg, Antitumor activity, induction of cross-resistance, and nephrotoxicity of a new platinum analogue, cis-1,1-diaminomethyl-cyclohexaneplatinum (II) sulfate, and of cis-diamminedichloroplatinum (II) in an immunocytoma model in the Lou/M rat, Cancer Res., 43, pp. 4927-4934, (1983)